US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

AFMD

Affimed NV (AFMD)

Affimed NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AFMD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/24	17 : 05	GlobeNewswire Inc.	Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology	NASDAQ:AFMD	Affimed NV
2024/03/28	19 : 30	GlobeNewswire Inc.	Affimed Reports 2023 Financial Results and Operational Progress	NASDAQ:AFMD	Affimed NV
2024/03/21	19 : 30	GlobeNewswire Inc.	Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024	NASDAQ:AFMD	Affimed NV
2024/03/12	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2024/03/06	20 : 34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2024/03/06	20 : 30	GlobeNewswire Inc.	Affimed Announces 1-for-10 Reverse Stock Split	NASDAQ:AFMD	Affimed NV
2024/01/09	06 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2024/01/09	06 : 05	GlobeNewswire Inc.	Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer	NASDAQ:AFMD	Affimed NV
2024/01/08	22 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2024/01/08	22 : 00	GlobeNewswire Inc.	Affimed Announces Leadership Change and Organizational Restructuring	NASDAQ:AFMD	Affimed NV
2024/01/03	20 : 30	GlobeNewswire Inc.	Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck	NASDAQ:AFMD	Affimed NV
2023/12/11	20 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2023/12/11	20 : 02	GlobeNewswire Inc.	Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients	NASDAQ:AFMD	Affimed NV
2023/12/11	20 : 00	GlobeNewswire Inc.	Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)	NASDAQ:AFMD	Affimed NV
2023/12/04	20 : 30	GlobeNewswire Inc.	Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24	NASDAQ:AFMD	Affimed NV
2023/11/30	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2023/11/14	20 : 30	GlobeNewswire Inc.	Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress	NASDAQ:AFMD	Affimed NV
2023/11/09	20 : 30	GlobeNewswire Inc.	Affimed Announces Acimtamig as International Nonproprietary Name for AFM13	NASDAQ:AFMD	Affimed NV
2023/11/07	20 : 30	GlobeNewswire Inc.	Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023	NASDAQ:AFMD	Affimed NV
2023/11/04	01 : 05	GlobeNewswire Inc.	Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer	NASDAQ:AFMD	Affimed NV
2023/11/02	22 : 05	GlobeNewswire Inc.	Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting	NASDAQ:AFMD	Affimed NV
2023/11/01	19 : 30	GlobeNewswire Inc.	Affimed to Participate in Upcoming Investor Conferences	NASDAQ:AFMD	Affimed NV
2023/10/04	19 : 40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV
2023/10/04	19 : 30	GlobeNewswire Inc.	Affimed Announces Listing Transfer to Nasdaq Capital Markets	NASDAQ:AFMD	Affimed NV
2023/09/27	22 : 05	GlobeNewswire Inc.	Affimed Announces Acceptance of an Abstract Comparing NK Cells Redirected by Innate Cell Engagers and CAR-NK Cells for Poster Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer	NASDAQ:AFMD	Affimed NV
2023/09/21	19 : 30	GlobeNewswire Inc.	Affimed to Present at the Cantor Global Healthcare Conference 2023	NASDAQ:AFMD	Affimed NV
2023/09/12	19 : 30	GlobeNewswire Inc.	Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma	NASDAQ:AFMD	Affimed NV
2023/09/07	19 : 30	GlobeNewswire Inc.	Affimed to Present at the H.C. Wainwright Annual Global Investment Conference	NASDAQ:AFMD	Affimed NV
2023/08/22	18 : 00	GlobeNewswire Inc.	Affimed Announces Publication in the Journal mAbs on Leveraging FcRn-pH-HPLC as a Method to Select Bispecific Antibodies with Optimal Developability	NASDAQ:AFMD	Affimed NV
2023/08/10	19 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AFMD	Affimed NV

Showing the most relevant articles for your search:NASDAQ:AFMD

1 2 3 4 5 6 7 8 9 10 次へ >>

JP Morgan Chase

American Express

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約